PAVM PAVmed Inc

Price (delayed)

$4.74

Market cap

$34.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$37.65

Enterprise value

$45.02M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 2

PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital ...

Highlights
PAVmed's revenue has plunged by 96% YoY but it has increased by 20% from the previous quarter
PAVM's gross profit has surged by 83% year-on-year but it is down by 31% since the previous quarter
The net income has dropped by 125% year-on-year
The EPS has dropped by 119% year-on-year

Key stats

What are the main financial stats of PAVM

PAVM stock price

How has the PAVmed stock price performed over time
Intraday
4.41%
1 week
-20%
1 month
1.5%
1 year
-73.02%
YTD
-28.4%
QTD
-20.2%

Financial performance

How have PAVmed's revenue and profit performed over time
Revenue
$85,000
Gross profit
-$193,000
Operating income
-$24.4M
Net income
-$18.63M
Gross margin
-227.1%
Net margin
-21,914.1%
The net income has dropped by 125% year-on-year
PAVmed's revenue has plunged by 96% YoY but it has increased by 20% from the previous quarter
PAVM's gross profit has surged by 83% year-on-year but it is down by 31% since the previous quarter
PAVM's operating income is up by 32% year-on-year but it is down by 12% since the previous quarter

Price vs fundamentals

How does PAVM's price correlate with its fundamentals

Growth

What is PAVmed's growth rate over time

Valuation

What is PAVmed stock price valuation
P/E
N/A
P/B
0.77
P/S
88.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
529.68
The EPS has dropped by 119% year-on-year
The stock's price to book (P/B) is 28% more than its last 4 quarters average of 0.6
The equity is up by 16% since the previous quarter but it has declined by 12% year-on-year
PAVmed's revenue has plunged by 96% YoY but it has increased by 20% from the previous quarter
The stock's price to sales (P/S) is 68% less than its 5-year quarterly average of 274.6 and 39% less than its last 4 quarters average of 145.6

Efficiency

How efficient is PAVmed business performance
PAVM's return on assets has dropped by 136% year-on-year
The company's return on invested capital has shrunk by 118% YoY

Dividends

What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PAVM.

Financial health

How did PAVmed financials performed over time
The total assets is 122% more than the total liabilities
The total liabilities has surged by 72% year-on-year and by 24% since the previous quarter
The total assets has grown by 17% from the previous quarter but it has contracted by 14% YoY
The debt is 57% less than the equity
PAVM's debt to equity has surged by 105% year-on-year and by 10% since the previous quarter
The debt has soared by 84% YoY and by 27% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.